Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
+20.47%
3Y annualised
+0.28% 1D
NAV: 28 Aug '26
₹25.12
Min. for SIP
Not Supported
Fund size (AUM)
₹195.49 Cr
Expense ratio
0.56%
Rating
3
Holdings (47)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.30% |
| Eli Lilly Forgn. Eq (LLY) | Healthcare | Foreign - Equity | 6.43% |
| Divi's Laboratories Ltd | Healthcare | Equity | 6.07% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.69% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 4.89% |
| Cipla Ltd | Healthcare | Equity | 4.69% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 4.61% |
| Johnson & Johnson Ltd. Forgn. Eq (JNJ) | Healthcare | Foreign - Equity | 4.30% |
| Laurus Labs Ltd | Healthcare | Equity | 4.02% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 3.63% |
| Lupin Ltd | Healthcare | Equity | 3.48% |
| AbbVie Inc Forgn. Eq (ABBV) | Healthcare | Foreign - Equity | 3.09% |
| Fortis Healthcare Ltd | Healthcare | Equity | 2.93% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 2.61% |
| Merck & Co Inc (US) Forgn. Eq (MRK) | Healthcare | Foreign - Equity | 2.24% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 1.99% |
| Novartis AG ADS/ADR (NVS) | Healthcare | ADS/ADR | 1.99% |
| Biocon Ltd | Healthcare | Equity | 1.74% |
| Mankind Pharma Ltd. | Healthcare | Equity | 1.61% |
| Ipca Laboratories Ltd | Healthcare | Equity | 1.54% |
| Alkem Laboratories Ltd | Healthcare | Equity | 1.52% |
| Thermo Fisher Scientific Inc Forgn. Eq (TMO) | Healthcare | Foreign - Equity | 1.49% |
| Amgen Inc. (USA) Forgn. Eq (AMGN) | Healthcare | Foreign - Equity | 1.45% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 1.32% |
| Abbott Laboratories Forgn. Eq (ABT) | Healthcare | Foreign - Equity | 1.28% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 1.21% |
| Gland Pharma Ltd | Healthcare | Equity | 1.17% |
| Gilead Sciences Inc. (USA) Forgn. Eq (GILD) | Healthcare | Foreign - Equity | 1.13% |
| Novo Nordisk A/S Forgn. Eq (NVO) | Healthcare | ADS/ADR | 1.06% |
| Ajanta Pharma Ltd | Healthcare | Equity | 0.96% |
| Intuitive Surgical Inc. (USA) Forgn. Eq (ISRG) | Healthcare | Foreign - Equity | 0.87% |
| Danaher Corporation Forgn. Eq (DHR) | Healthcare | Foreign - Equity | 0.87% |
| Vertex Pharmaceuticals Inc. (USA) Forgn. Eq (VRTX) | Healthcare | Foreign - Equity | 0.84% |
| Narayana Hrudayalaya Ltd | Healthcare | Equity | 0.78% |
| Stryker Corp Forgn. Eq (SYK) | Healthcare | Foreign - Equity | 0.78% |
| Medtronic Forgn. Eq (MDT) | Healthcare | Foreign - Equity | 0.76% |
| Global Health Ltd | Healthcare | Equity | 0.71% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 0.64% |
| Regeneron Pharmaceuticals Inc Forgn. Eq (REGN) | Healthcare | Foreign - Equity | 0.55% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 0.44% |
| Becton Dickinson And Co Forgn. Eq (BDX) | Healthcare | Foreign - Equity | 0.33% |
| Iqvia Holdings Forgn. Eq (IQV) | Healthcare | Foreign - Equity | 0.28% |
| Agilent Technologies Inc Forgn. Eq (A) | Healthcare | Foreign - Equity | 0.27% |
| Waters Corporation (WAT) | Healthcare | Foreign - Equity | 0.26% |
| Net Receivables | Unspecified | Net Receivables | 0.13% |
| Others CBLO | Unspecified | CBLO | 0.05% |
| Cash | Unspecified | Cash | 0.00% |
See All
Minimum investments
Min. for 1st investment
Not Supported
Min. for 2nd investment
Not Supported
Min. for SIP
Not Supported
Returns and rankings
Annualised returns
Absolute returns
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | +24.9% | +20.5% | +14.3% | +17.1% |
| Category average (Equity Sectoral) | -2.1% | +22.1% | +14.6% | -- |
| Rank (Equity Sectoral) | 7 | 12 | 9 | -- |
Exit load, stamp duty and tax
Exit load
Nil
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
AVAmit VoraFeb 2021 - PresentView details
AV
Amit Vora
Feb 2021 - Present
View details
BJBhavesh JainOct 2021 - PresentView details
BJ
Bhavesh Jain
Oct 2021 - Present
View details
MJManasi JalgaonkarApr 2026 - PresentView details
MJ
Manasi Jalgaonkar
Apr 2026 - Present
View details
About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is a Equity Mutual Fund Scheme launched by Edelweiss Mutual Fund. This scheme was made available to investors on 30 Apr 2008. Amit Vora is the Current Fund Manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹1,75,625 Cr and the Latest NAV as of 28 Aug 2026 is ₹25.12.
The Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100.
;
Investment Objective
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
Fund benchmarkMSCI India Domestic & World Healthcare 45 Index
Fund house
Rank (total assets)#15 in India
Total AUM₹1,75,624.70 Cr
Date of Incorporation30 Apr 2008
Launch Date30 Apr 2008
AddressEdelweiss HouseOff C.S.T. Road,Kalina Mumbai 400098
Websitewww.karvymfs.com
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,